辻野 一郎(つじの いちろう)

准教授，科長，外来医長，病棟医長

専門分野

呼吸器腫瘍学、肺癌化学療法、薬剤耐性、呼吸器病学

疾病認定医

医学博士、臨床研修指導医、総合内科専門医・指導医（日本内科学会）、呼吸器専門医・指導医（日本呼吸器学会）、東京都難病指定医

主な研究業績・著書

• 研究業績
• Yuta Ohishi, Yoko Nakanishi, Yukari Hirotani, Atsuko Suzuki, Tomoyuki Tanino, Haruna Nishimaki-Watanabe, Hiroko Kobayashi, Fumi Nozaki, Sumie Ohni, Xiaoyan Tang, Ketaro Hyashi, Yoshiko Nakagawa, Tetsuo Shimizu, Ichiro Tsujino, Noriaki Takahashi, Yasuhiro Gon, Shinobu Masuda: Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants. Thorac Cancer. 2024;15(1):89-93. doi: 10.1111/1759-7714.15168.
• 田中良磨、辻野一郎 他：化学療法中断後も腫瘍進行を認めない肺腺癌３症例の臨床的検討. 第63回日本呼吸器学会学術講演会 稀な腫瘍2023年4月東京.
• Tsujino Ichiro, et al: A case of stage IV lung adenocarcinoma with long-term survival for 18 years, finally found to be positive for EGFR gene mutations. The 25th Congress of the Asian Pacific Society of Respirology, Lung Cancer, 2021 November, Kyoto.
• Chikako Ichikawa, Ichiro Tsujino, et al: Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus. Therapeutics and Clinical Risk Management 2021:17 463–470.
• Tanaka S, Tsujino I, et al: Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report. Clin Diabetes Endocrinol. 2020 Jan 6;6-1.
• Ichiro Tsujino, Ryoko Ushikoshi_Nakayama, Tomoe Yamazaki, Naoyuki Matsumoto, and Ichiro Saito : Pulmonary activation of vitamin D and preventive effect against interstitial pneumonia. Journal of Clinical Biochemistry and Nutrition: vol.65 (3); 245–251, November 2019
• Tsujino I, Nakanishi Y, Hiranuma H, Shimizu T, Hirotani Y, Ohni S, Ouchi Y, Takahashi N, Nemoto N, Hashimoto S. Increased phosphorylation of ERK1/2 is associated with worse chemotherapeutic outcome and a poor prognosis in advanced lung adenocarcinoma. Medical Mollecular Morphology. 2016 Jun;49(2):98-109.
• 著書
• 「特定保険医療材料」解説　特材算定ハンドブック　監修川村雅文　医療材料実務研究会「呼吸器領域」　２０２４年度版　社会保険研究所.
• 「特定保険医療材料」解説　特材算定ハンドブック　監修川村雅文　医療材料実務研究会「呼吸器領域」　２０２２年度版　社会保険研究所

仲剛(なかごう)

病院准教授、副病棟医長

専門分野

呼吸器疾患、特に胸部腫瘍性疾患

疾病認定医

総合内科専門医、呼吸器専門医・指導医、がん薬物療法専門医・指導医、がん治療認定医

飯田由子(いいだゆうこ)

助教、医局長

専門分野

肺癌、呼吸器内科一般、緩和ケア

疾病認定医

医学博士、内科認定医（日本内科学会）、呼吸器専門医（日本呼吸器学会）、気管支鏡専門医（日本呼吸器内視鏡学会）、がん薬物療法専門医（日本臨床腫瘍学会）

主な研究業績・著書

• 1: Iida Y, et al., Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma. Sci Rep. 2024 Apr 1;14(1):7641.
• 2: Iida Y, et al., Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer. Thorac Cancer. 2024 Feb;15(6):477-485.
• 3: Iida Y, et al., Comprehensive genetic analysis of histological components of combined small cell carcinoma. Thorac Cancer. 2022 Aug;13(16):2362-2370.
• 4: Iida Y, et al., Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane. Oncology Letters. 2021 21(1):71.
• 5: Iida Y, et al., Genomic analysis between idiopathic pulmonary fibrosis and associated lung cancer using laser-assisted microdissection: A case report. Thorac Cancer. 2021 May;12(9):1449-1452.
• 6: Iida Y, et al., Successful treatment of an elderly patient with an uncommon L861Q epidermal growth factor receptor mutation with low-dose afatinib: A case report. Thorac Cancer. 2020 11(2):447-450.
• 7: Iida Y, et al., Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers. Human pathology 2018 79 :127 - 134.

神野優介(じんのゆうすけ)

専修医

専門分野

呼吸器内科一般

疾病認定医

内科専門医

大地康司(おおちやすじ)

植松昭仁(うえまつあきひと)